Open access · CC-BY
via OpenAlex
Age of onset moderates the effects of Vascular Risk Factors on Neurodegeneration, Blood-Brain-Barrier permeability, and cognitive decline in Alzheimer’s Disease
Chiara Giuseppina Bonomi, Caterina Motta, Martina Gaia Di Donna, Martina Poli, Marzia Nuccetelli, Sergio Bernardini, Nicola Biagio Mercuri, Giacomo Koch, Alessandro Martorana
Alzheimer s Research & Therapy · 2024 · ▲ 7 citations
Abstract
BACKGROUND: The role of Vascular risk factors (VRFs) in the progression of Alzheimer's Disease (AD) and cognitive decline remains to be elucidated, with previous studies resulting in conflicting findings. The possible impact of age-specific mechanisms of resilience/vulnerability is an under addressed issue. We evaluated the association of VRFs with markers of amyloid deposition, neurodegeneration, and blood-brain-barrier (BBB) permeability (Albumin quotient, Qalb), stratifying patients into early-onset (< 65, EOAD), classic late-onset (65-75, cLOAD) and very late-onset (> 75, vLOAD), to evaluate the moderating effect of age of onset. Moreover, we explored the effects of VRFs on cognitive decline at one year follow-up (ΔMMSE). METHODS: For 368 patients with biologically confirmed AD, we computed eight risk factors in a composite measure of cumulative vascular risk (vascular score, VS). Stratifying patients according to age of onset, we regressed VS and main individual VRFs on p-tau/Aβ42, t-tau and Qalb, and used bootstrapped mediation analysis to test direct and indirect associations of VS with t-tau, using Qalb as mediator. In a subset of 105 patients, we performed multivariate backward regressions to assess the effects of sex, APOE, Qalb, VS, p-tau/Aβ42 and t-tau on ΔMMSE. RESULTS: VS was positively associated with CSF t-tau in more vulnerable groups burdened by more aggressive disease progression (EOAD: β = 0.256, p = 0.019) or aging (vLOAD: β = 0.007, p < 0.001). Conversely, in patients with classic age of onset VS was associated with higher BBB permeability (cLOAD: β = 0.173, p = 0.015), which simultaneously causes the decrease of CSF t-tau, as a possible resilience response. Cognitive decline was not associated with VS in any of the subgroups. Instead, it was affected by both higher CSF t-tau and increased Qalb values in those with very early or very late onset (EOAD and vLOAD), but by Qalb alone in patients with classic age of onset, where CSF t-tau levels might be buffered by BBB permeability. CONCLUSIONS: Our results show that age of onset weighs on the heterogeneous effects played by VRFs in AD, which do not seem to have direct impact on cognitive decline. These findings stress the importance of a tailored patient-centered approach to the application of vascular prevention strategies in AD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1186/s13195-024-01617-2
- Canonical
- link ↗
- Fetched
- 2026-10-27 MST
Cite this
APA
Bonomi, C.G., Motta, C., Donna, M.G.D., Poli, M., Nuccetelli, M., Bernardini, S., Mercuri, N.B., Koch, G., & Martorana, A. (2024). Age of onset moderates the effects of Vascular Risk Factors on Neurodegeneration, Blood-Brain-Barrier permeability, and cognitive decline in Alzheimer’s Disease. <em>Alzheimer s Research & Therapy</em>. https://doi.org/10.1186/s13195-024-01617-2
Vancouver
Bonomi CG, Motta C, Donna MGD, Poli M, Nuccetelli M, Bernardini S, et al. Age of onset moderates the effects of Vascular Risk Factors on Neurodegeneration, Blood-Brain-Barrier permeability, and cognitive decline in Alzheimer’s Disease. Alzheimer s Research & Therapy. 2024. doi:10.1186/s13195-024-01617-2.
BibTeX
@article{chiara2024Ageofo,
title = {Age of onset moderates the effects of Vascular Risk Factors on Neurodegeneration, Blood-Brain-Barrier permeability, and cognitive decline in Alzheimer’s Disease},
author = {Chiara Giuseppina Bonomi and Caterina Motta and Martina Gaia Di Donna and Martina Poli and Marzia Nuccetelli and Sergio Bernardini and Nicola Biagio Mercuri and Giacomo Koch and Alessandro Martorana},
journal = {Alzheimer s Research & Therapy},
year = {2024},
doi = {10.1186/s13195-024-01617-2},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
2026
Preprint
Contribution of cerebrovascular lesions to neurodegeneration and cognitive decline
Frontiers in Nutrition 2025
Open access · CC-BY
The impact of serum uric acid on biological aging and mortality risk: insights from the NHANES and CHARLS cohorts
Clinical Epigenetics 2025
Open access · CC-BY
Unveiling the impact of DNA-methylation age acceleration on mortality risk in diabetes and pre-diabetes: insights from the US NHANES program
Clinical Epigenetics 2022
Open access · CC-BY
The association of accelerated epigenetic age with all-cause mortality in cardiac catheterization patients as mediated by vascular and cardiometabolic outcomes
Aging 2026
Citation only
Brain glucose metabolism and blood-brain barrier permeability in Alzheimer's disease continuum.
Dementia & Neuropsychologia 2016
Open access · CC-BY